EAST WINDSOR, N.J.--(BUSINESS WIRE)--NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on its proprietary NexACT® drug delivery technology, today announced that Mark Westgate, Chief Financial Officer, will make a company presentation at the NJTC Public/Private Company Showcase on Friday, October 5, 2007 at the Hyatt on the Hudson in Jersey City, New Jersey.
